Rituximab in Steroid-Dependent Podocytopathies
Rituximab (RTX) seems to be an effective treatment alternative in primary forms of MCD and FSGS, particularly in cases of steroid dependence and frequent relapses. Our findings support the use of RTX for a steroid-free remission in podocytopathies and suggest that maintenance RTX is well-tolerated and associated with prolonged remission. Further studies are needed to confirm its efficacy and safety and establish the optimal induction and maintenance RTX regimen in steroid-dependent podocytopathies.
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Rituximab in Steroid-Dependent Podocytopathies ; volume:4 ; number:1 ; year:2024 ; pages:129-136 ; extent:8
Glomerular Diseases ; 4, Heft 1 (2024), 129-136 (gesamt 8)
- Urheber
-
Costa, Cláudia
Antunes, Amélia
Oliveira, João
Pereira, Marta
Godinho, Iolanda
Fernandes, Paulo
Jorge, Sofia
Lopes, José António
Gameiro, Joana
- DOI
-
10.1159/000539922
- URN
-
urn:nbn:de:101:1-2412260109196.029145747586
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:27 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Costa, Cláudia
- Antunes, Amélia
- Oliveira, João
- Pereira, Marta
- Godinho, Iolanda
- Fernandes, Paulo
- Jorge, Sofia
- Lopes, José António
- Gameiro, Joana
Ähnliche Objekte (12)
Rituximab in steroid-sensitive nephrotic syndrome: lessons from clinical trials
Rituximab treatment for chronic steroid-dependent Henoch-Schonlein purpura: 8 cases and a review of the literature
Efficacy of Semiannual Single Fixed Low-Dose Rituximab Therapy in Steroid-Dependent Minimal Change Nephrotic Syndrome: A Case Series
Randomized clinical trial to compare efficacy and safety of repeated courses of rituximab to single-course rituximab followed by maintenance mycophenolate-mofetil in children with steroid dependent nephrotic syndrome
Obinutuzumab as a viable therapeutic strategy in rituximab-refractory childhood frequently relapsing, steroid-dependent nephrotic syndrome that relapsed during B-cell depletion
Steroid responsiveness of peripheral blood T cells derived from steroid sensitive, steroid dependent, and steroid resistant asthmatics, and induction of steroid resistance by costimulatory signal
Retarded release phosphatidylcholine in steroid dependent ulcerative colitis
Cost-effectiveness of adding rituximab to splenectomy and romiplostim for treating steroid-resistant idiopathic thrombocytopenic purpura in adults
Steroid-Spektrenatlas : = Atlas of steroid spectra
Steroid Receptor Coactivator 3 Regulates Synaptic Plasticity and Hippocampus-dependent Memory
Steroid-mediated liver steatosis is CD1d-dependent, while steroid-induced liver necrosis, inflammation, and metabolic changes are CD1d-independent
Four molybdenum-dependent steroid C-25 hydroxylases: Heterologous overproduction, role in steroid degradation, and application for 25-hydroxyvitamin D3 synthesis
Rituximab in steroid-sensitive nephrotic syndrome: lessons from clinical trials
Rituximab treatment for chronic steroid-dependent Henoch-Schonlein purpura: 8 cases and a review of the literature
Efficacy of Semiannual Single Fixed Low-Dose Rituximab Therapy in Steroid-Dependent Minimal Change Nephrotic Syndrome: A Case Series
Randomized clinical trial to compare efficacy and safety of repeated courses of rituximab to single-course rituximab followed by maintenance mycophenolate-mofetil in children with steroid dependent nephrotic syndrome
Obinutuzumab as a viable therapeutic strategy in rituximab-refractory childhood frequently relapsing, steroid-dependent nephrotic syndrome that relapsed during B-cell depletion
Steroid responsiveness of peripheral blood T cells derived from steroid sensitive, steroid dependent, and steroid resistant asthmatics, and induction of steroid resistance by costimulatory signal
Retarded release phosphatidylcholine in steroid dependent ulcerative colitis
Cost-effectiveness of adding rituximab to splenectomy and romiplostim for treating steroid-resistant idiopathic thrombocytopenic purpura in adults
Steroid-Spektrenatlas : = Atlas of steroid spectra
Steroid Receptor Coactivator 3 Regulates Synaptic Plasticity and Hippocampus-dependent Memory
Steroid-mediated liver steatosis is CD1d-dependent, while steroid-induced liver necrosis, inflammation, and metabolic changes are CD1d-independent
Four molybdenum-dependent steroid C-25 hydroxylases: Heterologous overproduction, role in steroid degradation, and application for 25-hydroxyvitamin D3 synthesis
Rituximab in steroid-sensitive nephrotic syndrome: lessons from clinical trials
Rituximab treatment for chronic steroid-dependent Henoch-Schonlein purpura: 8 cases and a review of the literature
Efficacy of Semiannual Single Fixed Low-Dose Rituximab Therapy in Steroid-Dependent Minimal Change Nephrotic Syndrome: A Case Series
Randomized clinical trial to compare efficacy and safety of repeated courses of rituximab to single-course rituximab followed by maintenance mycophenolate-mofetil in children with steroid dependent nephrotic syndrome
Obinutuzumab as a viable therapeutic strategy in rituximab-refractory childhood frequently relapsing, steroid-dependent nephrotic syndrome that relapsed during B-cell depletion
Steroid responsiveness of peripheral blood T cells derived from steroid sensitive, steroid dependent, and steroid resistant asthmatics, and induction of steroid resistance by costimulatory signal
Retarded release phosphatidylcholine in steroid dependent ulcerative colitis
Cost-effectiveness of adding rituximab to splenectomy and romiplostim for treating steroid-resistant idiopathic thrombocytopenic purpura in adults
Steroid-Spektrenatlas : = Atlas of steroid spectra
Steroid Receptor Coactivator 3 Regulates Synaptic Plasticity and Hippocampus-dependent Memory
Steroid-mediated liver steatosis is CD1d-dependent, while steroid-induced liver necrosis, inflammation, and metabolic changes are CD1d-independent